Delivery Order SPE2DB25D3404-SPE2DB26FULVF
Award Date 10/27/25
Potential Completion Date 10/28/25
Potential Value $6.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $23,648.20 by the Defense Logistics Agency for the supply of Lidocaine HCL 4% Solution in 4ml units. The contract, awarded on June 29, 2025, utilizes firm fixed pricing with a completion deadline of June 30, 2025. This delivery order is not subject to any set-aside designation and was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine HCL 4% Solution 4ML on June 10, 2025, with a ceiling value of $1,209.14 and ultimate completion date of June 11, 2025. This competitive award, issued under firm fixed-price terms with no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine HCL 4% Solution in 4ML vials, with a ceiling value of $1,806.12. This firm fixed-price delivery order, issued on August 27, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract is scheduled for ultimate completion by...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Lidocaine HCL 2% 200 mg/10 mL vials totaling $3,408.68 with a completion date of August 13, 2025. This is a firm fixed-price, non-set-aside contract with performance at the company's Conshohocken, Pennsylvania facility. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine HCL 4% Solution in 4ML vials, with a contract ceiling value of $1,569.39 and an ultimate completion date of August 21, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded competitively on August 20, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a $1,903.04 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Lidocaine HCL 1% 50 mg/5 ml vials (5 ml). This firm fixed-price delivery order, which represents a non-set-aside competitive award, is scheduled for completion by July 28, 2025, with performance based in Conshohocken, Pennsylvania. The contract leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine HCL 2% 40 mg/2 mL vials on August 14, 2025, with a ceiling value of $9,369.36 and firm fixed pricing. This non-set-aside, competitively awarded contract is classified as a delivery order with an ultimate completion date of August 15, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform under this award at its corporate office location. This...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp's Corporate Office division in Conshohocken, Pennsylvania. The $1,623.22 order is for the supply of Lidocaine HCL 4% Solution in 4 mL vials. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Lidocaine HCL 50ML in quantities of 25 units, with a contract value of $1,360.90. This is a firm fixed-price delivery order with no set-aside designation, meaning the award was made through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August...
- The Defense Department, through its Medical Supply Chain division, awarded a delivery order valued at $1,712.10 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Lidocaine HCL in 50ML quantities (25 units). The contract employs firm fixed pricing with no set-aside designation, indicating competitive award based on open competition. Performance will be executed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of...